Target intelligence / Profile preview

Immunoglobulin lambda variable 3-1 (IGLV3-1)

Target
IGLV3-1
Molecular classification
Immunoglobulin variable region, Immunoglobulin light chain, Other
01

Overview

Immunoglobulin lambda variable 3-1 is a gene encoding the variable domain of the lambda light chain of human antibodies (immunoglobulins), which are glycoproteins produced by B lymphocytes. The product of IGLV3-1 participates in the formation of the immunoglobulin antigen-binding site through somatic recombination (V-(D)-J rearrangement) and affinity maturation. In the immune response, membrane-bound immunoglobulins act as B cell receptors that, upon binding a specific antigen, induce clonal expansion and differentiation into plasma cells that secrete the immunoglobulin. The variable light chain region encoded by IGLV3-1 contributes to the specificity and diversity of antibody responses[1][5][11][12][14].

Other names
Ig lambda chain V-IV region BauIg lambda chain V-IV region MOLIg lambda chain V-IV region Ximmunoglobulin lambda variable 3-1IGLV3-1HGNC:5896NCBI Gene:28809Ensembl:ENSG00000211673UniProtKB: P01715
02

Mechanism of action

none

03

Biological functions

Antigen bindingHumoral immune responseB cell receptor diversity generationAdaptive immune response
04

Disease associations

Other (Linked through variation to risk for Autism Spectrum Disorder in genome-wide association studies, but no direct roles in cancer, inflammation, etc.)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-1 (IGLV3-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-1 (IGLV3-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call